Corrigendum to “Selection of quality markers of Jasminum amplexicaule based on its anti-diarrheal and anti-inflammatory activities: Effect-target affiliation-traceability-pharmacokinetics strategy” Chinese Herbal Medicines 11 (2019) 379–386 (Chinese Herbal Medicines (2019) 11(4) (379–386), (S167463841930070X), (10.1016/j.chmed.2019.08.002))
- Author:
Ai-li XU
1
;
Ping DING
1
;
Ai-li XU
2
;
Dong-mei SUN
2
;
Xiao-li BI
2
;
Da-ke CAI
2
;
Zhao CHEN
2
;
Xue-jun HUANG
2
;
Jie-yi JIANG
2
;
Ai-li XU
3
;
Dong-mei SUN
3
;
Xiao-li BI
3
;
Da-ke CAI
3
;
Zhao CHEN
3
;
Xue-jun HUANG
3
;
Jie-yi JIANG
3
;
Ai-li XU
4
;
Dong-mei SUN
4
;
Xiao-li BI
4
;
Da-ke CAI
4
;
Zhao CHEN
4
;
Xue-jun HUANG
4
;
Jie-yi JIANG
4
;
Bu-ming LIU
5
Author Information
- Publication Type:Journal Article
- From: Chinese Herbal Medicines 2021;13(2):293-293
- CountryChina
- Language:Chinese
- Abstract: When this paper was first published the following ethical statement was omitted in error: All animal experimental protocols were approved by the Animal Ethics Committee of Guangdong Provincial Engineering Technology Institute of Traditional Chinese Medicine (Guangzhou, Guangdong, China, Approval NO: 048483). Further, all methods were performed in accordance with the relevant guidelines and regulations. NIH mice were purchased from the Guangdong Medical Laboratory Animal Center (Guangzhou, Guangdong, China, Certificate NO.44007200031795). The authors would like to apologise for any inconvenience caused.